ÂÜÀòÂÒÂ×

Anthony Bevilacqua, PharmD has a diverse work experience in the pharmaceutical industry. Their most recent position was as the Senior Director of Medical Science Liaisons at Kura Oncology, Inc. starting in July 2022. Previously, they held the role of Senior Medical Science Liaison at the same company from June 2020 to July 2022.

Before joining Kura Oncology, Inc., Anthony worked at Eisai US from 2012 to 2020, where they held various roles in the Oncology department. These roles included Distinguished Medical Science Liaison, Senior Medical Science Liaison, and Medical Science Liaison. Anthony covered territories in New York City, Long Island, the Northeast states, and other regions.

Anthony also gained experience at Seattle Genetics and Englewood Hospital and Medical Center. At Seattle Genetics, they served as a Senior Medical Information Specialist and a Medical Information Specialist. At Englewood Hospital and Medical Center, they worked as a Staff Pharmacist.

Additionally, Anthony had a drug-information residency in scientific communications at Eisai.

Anthony Bevilacqua, PharmD attended the University of the Sciences in Philadelphia, where they earned their PharmD degree in Pharmacy. Anthony also pursued a Post-Doctoral Fellowship at Rutgers University, focusing on the Pharmaceutical Industry. In addition to their formal education, Bevilacqua obtained certification as a BCMAS (Board Certified Medical Affairs Specialist) from the Accreditation Council for Medical Affairs (ACMA) in July 2017.